secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001558370-25-006220
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iradimed Q1 record revenue $19.5M (+11% YoY); EPS $0.37 GAAP, $0.42 non-GAAP
----------------------------------------------------------------------------

- Record Q1 revenue of $19.5M, up 11% YoY from $17.6M; GAAP diluted EPS $0.37 (+16% YoY).
- Non-GAAP diluted EPS $0.42 (+17% YoY); excludes $0.7M stock compensation net of tax.
- Declared regular quarterly cash dividend of $0.17/share, payable May 30, 2025 to holders of record May 20.
- Q2 2025 guidance: revenue $19.7-19.9M; GAAP EPS $0.37-0.40; non-GAAP EPS $0.41-0.44.
- Reaffirms FY 2025 guidance: revenue $78-82M; GAAP EPS $1.55-1.65; non-GAAP EPS $1.71-1.81.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025006220/0001558370-25-006220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025006220/irmd-20250505x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-006220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer